Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02320513 · ClinicalTrials.gov registry record

A Comparison of Physical Activity Levels With and Without Feedback Via Fitbit® Flex™ in Hemodialysis Patients

A clinical trial of End Stage Renal Disease, sponsored by Renal Research Institute.

Completed
Registry status
33
Enrollment target
1
Study location

NCT02320513: Completed study of End Stage Renal Disease, sponsored by Renal Research Institute.

NCT02320513 is a study of End Stage Renal Disease that has completed, run by Renal Research Institute. The registered enrollment target is 33 participants, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02320513, a study of End Stage Renal Disease, has completed, sponsored by Renal Research Institute.

COMPLETED
Registry status
33 participants
Enrollment target
1
Study location

Study Summary

This is a pilot study intended to gather data in order to inform future studies about the role of feedback as an incentive for increasing levels of physical activity which could improve health in hemodialysis patients.

Primary Outcome

Physical activity level will be measured by the number of steps each subject takes. The number of steps each subject takes will be recorded and reported to those in one of the two groups. The study will evaluate whether a subject will begin to walk more steps once s/he is informed about the number of steps s/he is taking.

Conditions Studied

End Stage Renal Disease

Interventions

  • OTHER Wearing activty monitoring device (Fitbit Flex)
  • DEVICE Fitbit Flex

Study Locations (1)

New York

  • Avantua Upper East Side Dialysis Center - New York

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2014-10
Est. Completion 2015-06
Renal Research Institute

14 total trials

What the finished NCT02320513 record still lists

NCT02320513 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (96% lower).

The record links to 1 condition, with End Stage Renal Disease appearing as the primary indexed condition, and to 2 interventions - of which Wearing activty monitoring device (Fitbit Flex) is the first listed.

NCT02320513 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT02320513 about?

NCT02320513 is a clinical study titled "A Comparison of Physical Activity Levels With and Without Feedback Via Fitbit® Flex™ in Hemodialysis Patients". This is a pilot study intended to gather data in order to inform future studies about the role of feedback as an incentive for increasing levels of physical activity which could improve health in hemodialysis patients.

What is the current status of trial NCT02320513?

This trial is currently completed. The enrollment target is 33 participants. The study started on 2014-10. Estimated completion is 2015-06.

What conditions does trial NCT02320513 study?

This clinical trial studies the following conditions: End Stage Renal Disease.

What interventions are being tested in trial NCT02320513?

The interventions under investigation include: Wearing activty monitoring device (Fitbit Flex) (OTHER), Fitbit Flex (DEVICE).

Who is sponsoring clinical trial NCT02320513?

This trial is sponsored by Renal Research Institute, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02320513 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for End Stage Renal Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02320513's enrollment target sits among peer trials

33 59th of 86 higher than 28 of 86 other End Stage Renal Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other End Stage Renal Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02861898 · 33 participants · Phase 1

    Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

  • NCT04871607 · 33 participants · Phase 2

    Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma

  • NCT05071937 · 33 participants · Phase 2

    ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer

  • NCT05168618 · 33 participants · Phase 2

    Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT02320513, the US trial registry maintained by the National Library of Medicine. NCT02320513 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.